Member Info for SYN00GOLD

Yes, someone removed my post, but I couldn't care a jot 😉. Must have upset some folks, but I am relaxed. Some folks should try and have a decent conversation.

Enjoy the summer all genuine LTH's

Dr. Mika Kontro, MD, PhD, Associate Professor at the Helsinki University Hospital Comprehensive Cancer Center and Principal Investigator of the BEXMAB trial, said, “These results reinforce the potential of bexmarilimab to deliver clinically meaningful benefit in HR-MDS. A median duration of CR of 16.1 months in frontline patients is an encouraging signal, and the translational data add important biological depth. We are seeing evidence of genuine immune reprogramming in the bone marrow, with recovery of healthy progenitor cells and activation of cytotoxic T cell responses. Together, these findings provide a compelling foundation for the randomized Phase 2b BEXERA trial.”

You can tell from the trade price they are buys !

Yes HB

Exactly 2 months ago, you stated 'With the progress already underway, the Board believes 2026 will be a year of delivery, momentum, and success for ImmuPharma and its shareholders',

Do you still believe this statement to be true ?

Bank of America mopping up shares. 👍🫣

Musk : you have no grasp of the English language and you never contribute a single iota to any share.

As Wigwammer states, it’s a fact that if you were out at key moments, the boat was missed, whilst others made considerable profit.

Back in the bin 🤡

HELSINKI - Faron Pharmaceuticals Oy received notification that Bank of America Corporation crossed a major shareholding threshold, according to a press release statement issued Wednesday.

Bank of America Corporation, based in Wilmington, Delaware, holds 0.10% of shares and voting rights and 9.36% through financial instruments, resulting in a total position of 9.46% in Faron Pharmaceuticals. The threshold was crossed on May 26, 2026.

BeardedDragon : Bore off you complete imbecile, they are correct, wherever you post you bore everyone senseless and contribute less than zero. What is your point, you are like a broken pencil>>>>>>>>>POINTLESS !!! Maybe read some of your drivel and you will bore yourself and probably do what the rest of us do with you..........................into the green haze and good bye 😂🤦‍♂️

Be CLEVER-1

Correct, moving on more volume than in past 3 months and much more buying.

Volume already above mean day averages in Finland, LSE volume meaningless as per 🤣

As always, awaiting numerous key inflection points over next 18 months, should return above £1 to £1.50 mark

'With the progress already underway, the Board believes 2026 will be a year of delivery, momentum, and success for ImmuPharma and its shareholders.'

This was stated by Chairman just few weeks ago in RNS.

Patience will be rewarded as it has consistently over past few years. Many positive inflection points coming in next year or two and imo SP will reflect this in a very positive move north.

Who knows ??? Maybe update saying...................

Non conditional offer proposed at who knows what price 🤔😉🎉🎁 come on Tim, show us the deal !!

Totally agree Wigwammer, just to add,

'With the progress already underway, the Board believes 2026 will be a year of delivery, momentum, and success for ImmuPharma and its shareholders.'

This was stated by Chairman just 4 weeks ago in RNS.

Patience will be rewarded as it has consistently over past few years. Many positive inflection points coming in next year or two and imo SP will reflect this in a very positive move north.

Dr Sébastien Goudreau, Chief Scientific Officer of ImmuPharma PLC, said 5 weeks ago:

"The receipt of the first Combined Search and Examination Report for our UK P140 patent application, together with the new supporting study results, represents an important step in strengthening the scientific and intellectual property foundation of the program. In parallel, the scientific manuscript now in preparation will help the broader scientific community to understand the unique mechanism of P140 as a precision therapy for patients with Type M immune disorder. This work reinforces our confidence in P140's potential to become a first‑in‑class, disease‑modifying approach across multiple autoimmune diseases."

....................and remember

Our primary focus remains on securing a value-enhancing partnering agreement for our lead auto-immune technology platform, P140, during 2026. Recent progress continues to reinforce both the scientific rationale and commercial positioning of this program, and the management team is actively engaged in progressing discussions toward this objective.

The P140 update, issued on 27 March 2026, further strengthened the program's foundations, highlighting the first Combined Search and Examination Report for the UK patent application, supported by new study data. In addition, a scientific manuscript is now in preparation for submission to a peer-reviewed journal. Together, these developments enhance the credibility and long-term commercial potential of P140.

Following the General Meeting, we are now investing in our second key asset, Kapiglucagon, for type 1 diabetes. We have kickstarted an accelerated development program with a clear two-year plan, which was outlined in the recent Investor Meet Company presentation (https://www.immupharma.co.uk/updates/interviews/).The funding secured is structured to support this program, and we expect to announce regular progress updates over the next two years, as Kapiglucagon advances through its development program and towards potential partnering opportunities.

In April 2026, AstraZeneca closed the previously announced new strategic collaboration agreement with CSPC Pharmaceuticals to advance the development of multiple next-generation therapies for obesity and type 2 diabetes. AstraZeneca will pay an upfront payment of $1.2bn

Just added another 75K shares, brace yourself for a sharp rise in coming months...................................I have been loading up in past weeks and extremely happy, unlike some.

Good luck and health all LTH's

1st of many, at least 5 IIT's coming to a hospital near you soon...................Going to be many positives over coming 12 months !!

I just picked up another 122K shares, bargain basement and will rise significantly in coming months.

Many positive inflection points.